A truncated form of CD9-partner 1 (CD9P-1), GS-168AT2, potently inhibits in vivo tumour-induced angiogenesis and tumour growth

por Colin, S, Guilmain, W, Creoff, E, Schneider, C, Steverlynck, C, Bongaerts, M, Legrand, E, Vannier, J P, Muraine, M, Vasse, M, Al-Mahmood, S
Publicado 2011

Management of ocular involvement in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: french national audit of practices, literature review, and consensus...

por Thorel, D., Ingen-Housz-Oro, S., Royer, G., Delcampe, A., Bellon, N., Bodemer, C., Welfringer-Morin, A., Bremond-Gignac, D., Robert, M. P., Tauber, M., Malecaze, F., Dereure, O., Daien, V., Colin, A., Bernier, C., Couret, C., Vabres, B., Tetart, F., Milpied, B., Cornut, T., Ben Said, B., Burillon, C., Cordel, N., Beral, L., de Prost, N., Wolkenstein, P., Muraine, M., Gueudry, J.
Publicado 2020